{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:33:52Z","timestamp":1791498832344,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012825","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000}}],"reference-count":117,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["314730B_201266"],"award-info":[{"award-number":["314730B_201266"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["314730_172790"],"award-info":[{"award-number":["314730_172790"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["33CS30_201369"],"award-info":[{"award-number":["33CS30_201369"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SHCS research foundation"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>For use in prevention and treatment, HIV-1 broadly neutralizing antibodies (bnAbs) have to overcome Env conformational heterogeneity of viral quasispecies and neutralize with constant high potency. Comparative analysis of neutralization data from the CATNAP database revealed a nuanced relationship between bnAb activity and Env conformational flexibility, with substantial epitope-specific variation of bnAb potency ranging from increased to decreased activity against open, neutralization-sensitive Env. To systematically investigate the impact of variability in Env conformation on bnAb potency we screened 126 JR-CSF point mutants for generalized neutralization sensitivity to weakly neutralizing antibodies (weak-nAbs) depending on trimer opening and plasma from people with chronic HIV-1 infection. 23 mutations resulted in a highly neutralization sensitive phenotype, which was associated with de-stabilization of the closed, prefusion conformation. Including 19 of these mutants into a Sensitivity Env mutant panel (SENSE-19), we classified bnAbs according to potency variations in response to trimer opening. To verify that these sensitivity patterns are independent of the in vitro assay system, replication-competent SENSE-19 mutant viruses were tested on primary CD4 T cells. While loss of potency on SENSE-19 was registered for bnAbs from several classes recognizing quaternary epitopes on pre-triggered Env, structural destabilization benefitted MPER bnAbs and other inhibitors known to have post-CD4 attachment neutralization activity. Importantly, for a subset of CD4bs bnAbs, and the interface bnAb PGT151, particularly low potency variation was noted, suggesting that Env conformational tolerance can be achieved but is not the rule. In summary, SENSE-19 screens revealed distinct tolerance levels to Env conformational intermediates between bnAbs that provide mechanistic insights in their function and broaden current neutralization breadth assessments.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012825","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:34:12Z","timestamp":1737466452000},"page":"e1012825","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity"],"prefix":"10.1371","volume":"21","author":[{"given":"Caio","family":"Foulkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0694-657X","authenticated-orcid":true,"given":"Nikolas","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Stiegeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Karakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huldrych F.","family":"G\u00fcnthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Pasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rusert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-876X","authenticated-orcid":true,"given":"Alexandra","family":"Trkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"3","key":"ppat.1012825.ref001","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"BF Haynes","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"ppat.1012825.ref002","doi-asserted-by":"crossref","first-page":"109809","DOI":"10.1016\/j.clim.2023.109809","article-title":"Broadly neutralizing antibodies targeting HIV: progress and challenges","volume":"257","author":"N Paneerselvam","year":"2023","journal-title":"Clin Immunol"},{"issue":"4","key":"ppat.1012825.ref003","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/COH.0000000000000796","article-title":"Engineering strategies of Anti-HIV antibody therapeutics in clinical development","volume":"18","author":"N Pihlstrom","year":"2023","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"ppat.1012825.ref004","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1172\/JCI134395","article-title":"Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound","volume":"130","author":"EM Cale","year":"2020","journal-title":"J Clin Invest"},{"issue":"7613","key":"ppat.1012825.ref005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"JF Scheid","year":"2016","journal-title":"Nature"},{"issue":"11","key":"ppat.1012825.ref006","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","volume":"384","author":"L Corey","year":"2021","journal-title":"N Engl J Med"},{"key":"ppat.1012825.ref007","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1038\/ncomms7144","article-title":"Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env","volume":"6","author":"M Guttman","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"ppat.1012825.ref008","doi-asserted-by":"crossref","first-page":"7191","DOI":"10.1128\/JVI.03284-12","article-title":"HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1","volume":"87","author":"AK Harris","year":"2013","journal-title":"J Virol"},{"issue":"7663","key":"ppat.1012825.ref009","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature23010","article-title":"Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike","volume":"547","author":"G Ozorowski","year":"2017","journal-title":"Nature"},{"issue":"7","key":"ppat.1012825.ref010","doi-asserted-by":"crossref","first-page":"e1004966","DOI":"10.1371\/journal.ppat.1004966","article-title":"Capacity of broadly neutralizing antibodies to inhibit HIV-1 cell-cell transmission is strain- and epitope-dependent","volume":"11","author":"L Reh","year":"2015","journal-title":"PLoS Pathog"},{"issue":"7","key":"ppat.1012825.ref011","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20110196","article-title":"Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies","volume":"208","author":"P Rusert","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"ppat.1012825.ref012","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41467-022-28424-3","article-title":"Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer","volume":"13","author":"Z Yang","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"ppat.1012825.ref013","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","article-title":"Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors","volume":"161","author":"T Zhou","year":"2015","journal-title":"Cell"},{"issue":"5","key":"ppat.1012825.ref014","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.chom.2013.10.006","article-title":"Modeling virus- and antibody-specific factors to predict human immunodeficiency virus neutralization efficiency","volume":"14","author":"H Haim","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"1","key":"ppat.1012825.ref015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41467-017-01119-w","article-title":"The \u03b220-\u03b221 of gp120 is a regulatory switch for HIV-1 Env conformational transitions","volume":"8","author":"A Herschhorn","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"ppat.1012825.ref016","doi-asserted-by":"crossref","first-page":"e01598-16","DOI":"10.1128\/mBio.01598-16","article-title":"Release of gp120 restraints leads to an entry-competent intermediate state of the HIV-1 envelope glycoproteins","volume":"7","author":"A Herschhorn","year":"2016","journal-title":"mBio"},{"issue":"6210","key":"ppat.1012825.ref017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.1254426","article-title":"Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions","volume":"346","author":"JB Munro","year":"2014","journal-title":"Science"},{"issue":"7989","key":"ppat.1012825.ref018","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41586-023-06639-8","article-title":"Intermediate conformations of CD4-bound HIV-1 Env heterotrimers","volume":"623","author":"K-MA Dam","year":"2023","journal-title":"Nature"},{"issue":"7989","key":"ppat.1012825.ref019","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41586-023-06762-6","article-title":"HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes","volume":"623","author":"W Li","year":"2023","journal-title":"Nature"},{"issue":"8","key":"ppat.1012825.ref020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tim.2020.03.007","article-title":"The conformational states of the HIV-1 envelope glycoproteins","volume":"28","author":"Q Wang","year":"2020","journal-title":"Trends Microbiol"},{"issue":"1","key":"ppat.1012825.ref021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12977-023-00624-9","article-title":"Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization","volume":"20","author":"P Colin","year":"2023","journal-title":"Retrovirology"},{"issue":"6916","key":"ppat.1012825.ref022","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"PD Kwong","year":"2002","journal-title":"Nature"},{"issue":"7","key":"ppat.1012825.ref023","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"DD Richman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6929","key":"ppat.1012825.ref024","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"issue":"1","key":"ppat.1012825.ref025","doi-asserted-by":"crossref","first-page":"e3000114","DOI":"10.1371\/journal.pbio.3000114","article-title":"CD4 occupancy triggers sequential pre-fusion conformational states of the HIV-1 envelope trimer with relevance for broadly neutralizing antibody activity","volume":"17","author":"B Ivan","year":"2019","journal-title":"PLoS Biol"},{"issue":"1","key":"ppat.1012825.ref026","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41467-019-10899-2","article-title":"Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations","volume":"10","author":"Q Han","year":"2019","journal-title":"Nat Commun"},{"key":"ppat.1012825.ref027","article-title":"HIV-1-envelope trimer transitions from prefusion-closed to CD4-bound-open conformations through an occluded-intermediate state","author":"M Lee","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"ppat.1012825.ref028","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1038\/s41467-024-51656-4","article-title":"Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted\/founder sensitivity to broadly neutralizing antibodies","volume":"15","author":"D Parthasarathy","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"ppat.1012825.ref029","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2018.09.003","article-title":"Partially open HIV-1 envelope structures exhibit conformational changes relevant for coreceptor binding and fusion","volume":"24","author":"H Wang","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"ppat.1012825.ref030","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/s41467-024-48514-8","article-title":"Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains","volume":"15","author":"S Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"24","key":"ppat.1012825.ref031","doi-asserted-by":"crossref","first-page":"e0108222","DOI":"10.1128\/jvi.01082-22","article-title":"Antibody recognition of CD4-induced open HIV-1 Env trimers","volume":"96","author":"Z Yang","year":"2022","journal-title":"J Virol"},{"issue":"3","key":"ppat.1012825.ref032","doi-asserted-by":"crossref","first-page":"e1006255","DOI":"10.1371\/journal.ppat.1006255","article-title":"Delineating CD4 dependency of HIV-1: adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality","volume":"13","author":"D Beauparlant","year":"2017","journal-title":"PLoS Pathog"},{"issue":"16","key":"ppat.1012825.ref033","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.00756-11","article-title":"Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity","volume":"85","author":"BK Chakrabarti","year":"2011","journal-title":"J Virol"},{"issue":"6","key":"ppat.1012825.ref034","doi-asserted-by":"crossref","first-page":"e1002101","DOI":"10.1371\/journal.ppat.1002101","article-title":"Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity","volume":"7","author":"H Haim","year":"2011","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1012825.ref035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/JVI.01834-12","article-title":"Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism","volume":"87","author":"O O\u2019Connell","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"ppat.1012825.ref036","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JVI.02108-09","article-title":"Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies","volume":"84","author":"MS Seaman","year":"2010","journal-title":"J Virol"},{"issue":"7424","key":"ppat.1012825.ref037","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"7365","key":"ppat.1012825.ref038","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"issue":"5993","key":"ppat.1012825.ref039","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"18","key":"ppat.1012825.ref040","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1128\/JVI.00984-13","article-title":"Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains","volume":"87","author":"G-Y Chuang","year":"2013","journal-title":"J Virol"},{"issue":"6133","key":"ppat.1012825.ref041","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.1233989","article-title":"Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization","volume":"340","author":"IS Georgiev","year":"2013","journal-title":"Science"},{"issue":"5","key":"ppat.1012825.ref042","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.02853-13","article-title":"Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"88","author":"A deCamp","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"ppat.1012825.ref043","doi-asserted-by":"crossref","first-page":"e1006148","DOI":"10.1371\/journal.ppat.1006148","article-title":"Mapping polyclonal HIV-1 antibody responses via next-generation neutralization fingerprinting","volume":"13","author":"NA Doria-Rose","year":"2017","journal-title":"PLoS Pathog"},{"issue":"9","key":"ppat.1012825.ref044","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/v13091774","article-title":"A structural update of neutralizing epitopes on the HIV envelope, a moving target","volume":"13","author":"E Parker Miller","year":"2021","journal-title":"Viruses"},{"issue":"9","key":"ppat.1012825.ref045","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"RW Sanders","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6","key":"ppat.1012825.ref046","doi-asserted-by":"crossref","first-page":"e00955-18","DOI":"10.1128\/mBio.00955-18","article-title":"Structural constraints at the trimer apex stabilize the HIV-1 envelope in a closed, antibody-protected conformation","volume":"9","author":"C Guzzo","year":"2018","journal-title":"mBio"},{"issue":"17","key":"ppat.1012825.ref047","doi-asserted-by":"crossref","first-page":"e00410-17","DOI":"10.1128\/JVI.00410-17","article-title":"Plasticity and epitope exposure of the HIV-1 envelope trimer","volume":"91","author":"RLR Powell","year":"2017","journal-title":"J Virol"},{"issue":"W1","key":"ppat.1012825.ref048","doi-asserted-by":"crossref","first-page":"W213-9","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"H Yoon","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ppat.1012825.ref049","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20180246","article-title":"Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity","volume":"215","author":"C Kadelka","year":"2018","journal-title":"J Exp Med"},{"issue":"10","key":"ppat.1012825.ref050","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ebiom.2015.09.001","article-title":"HIV-specific CD4-induced antibodies mediate broad and potent antibody-dependent cellular cytotoxicity activity and are commonly detected in plasma from HIV-infected humans","volume":"2","author":"KL Williams","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"ppat.1012825.ref051","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1038\/s41467-021-27075-0","article-title":"Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization","volume":"12","author":"N Friedrich","year":"2021","journal-title":"Nat Commun"},{"issue":"17","key":"ppat.1012825.ref052","doi-asserted-by":"crossref","first-page":"e00410-17","DOI":"10.1128\/JVI.00410-17","article-title":"Plasticity and epitope exposure of the HIV-1 envelope trimer","volume":"91","author":"RLR Powell","year":"2017","journal-title":"J Virol"},{"issue":"1","key":"ppat.1012825.ref053","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/JVI.77.1.642-658.2003","article-title":"Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120","volume":"77","author":"R Pantophlet","year":"2003","journal-title":"J Virol"},{"issue":"5950","key":"ppat.1012825.ref054","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"issue":"3","key":"ppat.1012825.ref055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.20101907","article-title":"MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1","volume":"208","author":"CR Ruprecht","year":"2011","journal-title":"J Exp Med"},{"issue":"6165","key":"ppat.1012825.ref056","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"J-P Julien","year":"2013","journal-title":"Science"},{"issue":"4","key":"ppat.1012825.ref057","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G","volume":"165","author":"GBE Stewart-Jones","year":"2016","journal-title":"Cell"},{"issue":"5628","key":"ppat.1012825.ref058","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"DA Calarese","year":"2003","journal-title":"Science"},{"issue":"7","key":"ppat.1012825.ref059","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"L Kong","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"ppat.1012825.ref060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.immuni.2017.03.017","article-title":"A broadly neutralizing antibody targets the dynamic HIV envelope trimer apex via a long, rigidified, and anionic \u03b2-hairpin structure","volume":"46","author":"JH Lee","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"ppat.1012825.ref061","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.09.009","article-title":"Structural evolution of glycan recognition by a family of potent HIV antibodies","volume":"159","author":"F Garces","year":"2014","journal-title":"Cell"},{"issue":"1","key":"ppat.1012825.ref062","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2016.06.026","article-title":"A prominent site of antibody vulnerability on HIV envelope incorporates a motif associated with CCR5 binding and its camouflaging glycans","volume":"45","author":"D Sok","year":"2016","journal-title":"Immunity"},{"issue":"6686","key":"ppat.1012825.ref063","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"PD Kwong","year":"1998","journal-title":"Nature"},{"issue":"7209","key":"ppat.1012825.ref064","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"J Liu","year":"2008","journal-title":"Nature"},{"issue":"5371","key":"ppat.1012825.ref065","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"CD Rizzuto","year":"1998","journal-title":"Science"},{"issue":"6","key":"ppat.1012825.ref066","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","article-title":"CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization","volume":"72","author":"N Sullivan","year":"1998","journal-title":"J Virol"},{"issue":"6605","key":"ppat.1012825.ref067","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/384184a0","article-title":"CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5","volume":"384","author":"A Trkola","year":"1996","journal-title":"Nature"},{"issue":"9","key":"ppat.1012825.ref068","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41594-023-01062-z","article-title":"Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization","volume":"30","author":"M Gl\u00f6gl","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"ppat.1012825.ref069","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-biophys-060414-034156","article-title":"Structure and immune recognition of the HIV glycan shield","volume":"47","author":"M Crispin","year":"2018","journal-title":"Annu Rev Biophys"},{"issue":"45","key":"ppat.1012825.ref070","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.1073\/pnas.2000260117","article-title":"Visualization of the HIV-1 Env glycan shield across scales","volume":"117","author":"ZT Berndsen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1012825.ref071","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/prot.24747","article-title":"Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262","volume":"83","author":"L Kong","year":"2015","journal-title":"Proteins"},{"issue":"5","key":"ppat.1012825.ref072","doi-asserted-by":"crossref","first-page":"e1004932","DOI":"10.1371\/journal.ppat.1004932","article-title":"Vaccine-elicited tier 2 HIV-1 neutralizing antibodies bind to quaternary epitopes involving glycan-deficient patches proximal to the CD4 binding site","volume":"11","author":"ET Crooks","year":"2015","journal-title":"PLoS Pathog"},{"issue":"10","key":"ppat.1012825.ref073","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1128\/JVI.73.10.8120-8126.1999","article-title":"Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication","volume":"73","author":"P Kolchinsky","year":"1999","journal-title":"J Virol"},{"issue":"7","key":"ppat.1012825.ref074","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/JVI.02587-09","article-title":"A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer","volume":"84","author":"S-H Xiang","year":"2010","journal-title":"J Virol"},{"issue":"7523","key":"ppat.1012825.ref075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"M Pancera","year":"2014","journal-title":"Nature"},{"issue":"2","key":"ppat.1012825.ref076","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375","author":"VR Polonis","year":"2008","journal-title":"Virology"},{"issue":"2","key":"ppat.1012825.ref077","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.virol.2008.02.022","article-title":"Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models","volume":"375","author":"BK Brown","year":"2008","journal-title":"Virology"},{"issue":"5","key":"ppat.1012825.ref078","doi-asserted-by":"crossref","first-page":"e01883-17","DOI":"10.1128\/JVI.01883-17","article-title":"Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells","volume":"92","author":"YZ Cohen","year":"2018","journal-title":"J Virol"},{"issue":"13","key":"ppat.1012825.ref079","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/QAD.0b013e32832e9408","article-title":"HIV sensitivity to neutralization is determined by target and virus producer cell properties","volume":"23","author":"AM Mann","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"ppat.1012825.ref080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/COH.0b013e32832edc50","article-title":"Impact of host cell variation on the neutralization of HIV-1 in vitro","volume":"4","author":"VR Polonis","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"ppat.1012825.ref081","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/QAD.0b013e32832d92c2","article-title":"Divergent effects of cell environment on HIV entry inhibitor activity","volume":"23","author":"P Rusert","year":"2009","journal-title":"AIDS"},{"issue":"8","key":"ppat.1012825.ref082","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1073\/pnas.1314718111","article-title":"Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity","volume":"111","author":"R Cimbro","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ppat.1012825.ref083","doi-asserted-by":"crossref","first-page":"e01909-20","DOI":"10.1128\/JVI.01909-20","article-title":"Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against primary African isolates","volume":"95","author":"JCC Lorenzi","year":"2021","journal-title":"J Virol"},{"issue":"6","key":"ppat.1012825.ref084","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chom.2017.05.003","article-title":"Comprehensive mapping of HIV-1 escape from a broadly neutralizing antibody","volume":"21","author":"AS Dingens","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"1","key":"ppat.1012825.ref085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/bioinformatics\/btu587","article-title":"VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering","volume":"31","author":"BMP Verbist","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"ppat.1012825.ref086","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44298-023-00002-4","article-title":"An HIV-1 broadly neutralizing antibody overcomes structural and dynamic variation through highly focused epitope targeting","volume":"1","author":"EA Hodge","year":"2023","journal-title":"Npj Viruses"},{"issue":"12","key":"ppat.1012825.ref087","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1016\/S2352-3018(18)30174-7","article-title":"Preventive and therapeutic features of broadly neutralising monoclonal antibodies against HIV-1","volume":"5","author":"JP Jaworski","year":"2018","journal-title":"Lancet HIV"},{"key":"ppat.1012825.ref088","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2016.08.045","article-title":"Amino acid changes in the HIV-1 gp41 membrane proximal region control virus neutralization sensitivity","volume":"12","author":"T Bradley","year":"2016","journal-title":"EBioMedicine"},{"issue":"22","key":"ppat.1012825.ref089","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1128\/JVI.01352-12","article-title":"Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodies","volume":"86","author":"SM O\u2019Rourke","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"ppat.1012825.ref090","doi-asserted-by":"crossref","first-page":"e02219-16","DOI":"10.1128\/JVI.02219-16","article-title":"Residues in the gp41 ectodomain regulate HIV-1 envelope glycoprotein conformational transitions induced by gp120-directed inhibitors","volume":"91","author":"B Pacheco","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"ppat.1012825.ref091","doi-asserted-by":"crossref","first-page":"e37157","DOI":"10.1371\/journal.pone.0037157","article-title":"Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity","volume":"7","author":"R Ringe","year":"2012","journal-title":"PLoS One"},{"issue":"6151","key":"ppat.1012825.ref092","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/331082a0","article-title":"A soluble form of CD4 (T4) protein inhibits AIDS virus infection","volume":"331","author":"KC Deen","year":"1988","journal-title":"Nature"},{"issue":"6151","key":"ppat.1012825.ref093","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/331076a0","article-title":"HIV infection is blocked in vitro by recombinant soluble CD4","volume":"331","author":"RA Fisher","year":"1988","journal-title":"Nature"},{"issue":"5","key":"ppat.1012825.ref094","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/aid.1995.11.533","article-title":"Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates","volume":"11","author":"GP Allaway","year":"1995","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"19","key":"ppat.1012825.ref095","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.89.19.9339","article-title":"Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro","volume":"89","author":"CF Barbas","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"ppat.1012825.ref096","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(97)00043-6","article-title":"Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design","volume":"57","author":"PW Parren","year":"1997","journal-title":"Immunol Lett"},{"issue":"49","key":"ppat.1012825.ref097","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"D Sok","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ppat.1012825.ref098","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/jvi.70.2.1100-1108.1996","article-title":"Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1","volume":"70","author":"A Trkola","year":"1996","journal-title":"J Virol"},{"issue":"11","key":"ppat.1012825.ref099","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1128\/jvi.67.11.6642-6647.1993","article-title":"A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1","volume":"67","author":"T Muster","year":"1993","journal-title":"J Virol"},{"issue":"18","key":"ppat.1012825.ref100","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"G Stiegler","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"22","key":"ppat.1012825.ref101","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"MB Zwick","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"ppat.1012825.ref102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/aid.1994.10.359","article-title":"Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization","volume":"10","author":"A Buchacher","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7238","key":"ppat.1012825.ref103","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"JF Scheid","year":"2009","journal-title":"Nature"},{"issue":"12","key":"ppat.1012825.ref104","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1128\/jvi.66.12.7538-7542.1992","article-title":"Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody","volume":"66","author":"MK Gorny","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"ppat.1012825.ref105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ije\/dyab141","article-title":"Cohort profile update: the Swiss HIV cohort study (SHCS)","volume":"51","author":"AU Scherrer","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"6","key":"ppat.1012825.ref106","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cid\/civ398","article-title":"Frequency and spectrum of unexpected clinical manifestations of primary HIV-1 infection","volume":"61","author":"DL Braun","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ppat.1012825.ref107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.virol.2004.05.022","article-title":"Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol","volume":"326","author":"P Rusert","year":"2004","journal-title":"Virology"},{"issue":"2","key":"ppat.1012825.ref108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant","volume":"80","author":"X Wu","year":"2006","journal-title":"J Virol"},{"issue":"4803","key":"ppat.1012825.ref109","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.3646751","article-title":"Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms","volume":"236","author":"Y Koyanagi","year":"1987","journal-title":"Science"},{"key":"ppat.1012825.ref110","doi-asserted-by":"crossref","first-page":"107537","DOI":"10.1016\/j.biotechadv.2020.107537","article-title":"Library preparation for next generation sequencing: a review of automation strategies","volume":"41","author":"JF Hess","year":"2020","journal-title":"Biotechnol Adv"},{"issue":"4","key":"ppat.1012825.ref111","doi-asserted-by":"crossref","first-page":"e94249","DOI":"10.1371\/journal.pone.0094249","article-title":"Analysis, optimization and verification of illumina-generated 16S rRNA gene amplicon surveys","volume":"9","author":"MC Nelson","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1012825.ref112","doi-asserted-by":"crossref","first-page":"e1004595","DOI":"10.1371\/journal.ppat.1004595","article-title":"Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry","volume":"11","author":"OF Brandenberg","year":"2015","journal-title":"PLoS Pathog"},{"key":"ppat.1012825.ref113","author":"H Li","year":"2023"},{"key":"ppat.1012825.ref114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2009"},{"issue":"9","key":"ppat.1012825.ref115","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/bioinformatics\/btx657","article-title":"heatmaply: an R package for creating interactive cluster heatmaps for online publishing","volume":"34","author":"T Galili","year":"2018","journal-title":"Bioinformatics"},{"issue":"43","key":"ppat.1012825.ref116","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"H Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"ppat.1012825.ref117","author":"FE Harrell","year":"2023"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012825","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T13:59:25Z","timestamp":1738072765000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012825"}},"subtitle":[],"editor":[{"given":"Daniel C.","family":"Douek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012825","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.13.612684","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}